Scientists believe combining navitoclax with ruxolitinib will help those with myelofibrosis. On this trial half the folks have navitoclax and ruxolitinib. Another 50 % have ruxolitinib along with a dummy drug (placebo ). In animal research, navitoclax was uncovered to get a senolytic agent, inducing apoptosis in senescent, although not https://louismykv009898.blogspothub.com/25853462/epostane-secrets